|
|
|
Volumn 15, Issue 5, 2000, Pages 265-272
|
|
Asthma in women, Part 3: Perimenstrual asthma, effects of hormone therapy. Sensitivity to these and other sex-specific concerns improves disease control
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CORTICOSTEROID;
ESTROGEN;
GONADORELIN DERIVATIVE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MAGNESIUM SULFATE;
ORAL CONTRACEPTIVE AGENT;
PROGESTERONE;
THEOPHYLLINE;
XANTHINE DERIVATIVE;
ASTHMA;
BRONCHUS HYPERREACTIVITY;
DISABILITY;
ESTROGEN DEFICIENCY;
ESTROGEN THERAPY;
FEMALE;
HORMONE SUBSTITUTION;
HUMAN;
MENOPAUSE;
MENSTRUAL CYCLE;
ORAL CONTRACEPTION;
PEAK EXPIRATORY FLOW;
REVIEW;
SEX DIFFERENCE;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
|
|
EID: 0034027567
PISSN: 10400257
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (30)
|
